| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,161 |
14,627 |
$1.04M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,430 |
17,092 |
$864K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,371 |
2,316 |
$177K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,699 |
1,658 |
$110K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
2,125 |
2,055 |
$96K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,548 |
2,488 |
$85K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,164 |
2,119 |
$52K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,541 |
4,369 |
$52K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,847 |
1,772 |
$51K |
| 99215 |
Prolong outpt/office vis |
488 |
445 |
$49K |
| 36415 |
Collection of venous blood by venipuncture |
10,784 |
9,763 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,334 |
2,217 |
$26K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
312 |
307 |
$20K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,322 |
1,268 |
$16K |
| 80053 |
Comprehensive metabolic panel |
1,687 |
1,614 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
206 |
204 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
943 |
925 |
$12K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
143 |
141 |
$12K |
| 80061 |
Lipid panel |
1,070 |
1,050 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,200 |
1,179 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
333 |
320 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
303 |
292 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
631 |
608 |
$10K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
93 |
92 |
$9K |
| 87081 |
|
1,815 |
1,718 |
$9K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,484 |
1,310 |
$9K |
| 90686 |
|
1,507 |
1,473 |
$8K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
140 |
137 |
$8K |
| X5622 |
|
941 |
913 |
$8K |
| 96127 |
|
1,372 |
1,339 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
100 |
100 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
120 |
118 |
$6K |
| 85027 |
|
890 |
842 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
70 |
61 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
178 |
172 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
537 |
508 |
$4K |
| 99188 |
|
477 |
466 |
$4K |
| 87210 |
|
697 |
661 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
139 |
138 |
$3K |
| 81001 |
|
1,244 |
1,171 |
$3K |
| 92551 |
|
604 |
595 |
$3K |
| 92015 |
Determination of refractive state |
334 |
330 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
413 |
400 |
$3K |
| 86803 |
|
153 |
149 |
$2K |
| 99000 |
|
143 |
142 |
$2K |
| 90682 |
|
51 |
51 |
$2K |
| 99421 |
|
310 |
292 |
$1K |
| 99442 |
|
58 |
33 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
65 |
65 |
$1K |
| 90715 |
|
92 |
92 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
24 |
24 |
$1K |
| 90480 |
|
45 |
45 |
$1K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
46 |
46 |
$1K |
| 90651 |
|
31 |
30 |
$980.11 |
| 91320 |
|
12 |
12 |
$917.08 |
| 90656 |
|
116 |
115 |
$912.11 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$705.24 |
| 99173 |
|
659 |
649 |
$655.03 |
| 0071A |
|
14 |
14 |
$560.14 |
| 0004A |
|
15 |
15 |
$546.15 |
| 99443 |
|
19 |
12 |
$545.24 |
| 82728 |
|
37 |
37 |
$504.14 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
13 |
13 |
$486.44 |
| 87807 |
|
34 |
34 |
$450.05 |
| 93000 |
|
55 |
53 |
$390.26 |
| 0124A |
|
13 |
13 |
$360.53 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
12 |
12 |
$328.34 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
63 |
52 |
$263.91 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
13 |
13 |
$258.16 |
| 81025 |
|
28 |
28 |
$229.37 |
| 36416 |
|
86 |
64 |
$214.93 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
129 |
126 |
$202.99 |
| 81003 |
|
91 |
89 |
$172.04 |
| G0008 |
Administration of influenza virus vaccine |
28 |
25 |
$138.64 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
17 |
13 |
$138.30 |
| 90734 |
|
13 |
13 |
$120.73 |
| 82043 |
|
12 |
12 |
$69.25 |
| 84439 |
|
14 |
12 |
$33.01 |
| 84703 |
|
13 |
12 |
$9.83 |
| 85652 |
|
31 |
25 |
$0.20 |
| 90670 |
|
25 |
25 |
$0.00 |
| 90685 |
|
40 |
40 |
$0.00 |
| 90633 |
|
12 |
12 |
$0.00 |
| 90698 |
|
36 |
36 |
$0.00 |